Table 1.
Antimicrobial resistance profiles of S. Heidelberg isolates collected from human patients
| Resistance profilea | No. of isolates from: |
Total no. of isolates | % of isolates | ||
|---|---|---|---|---|---|
| ARb | NYc | WId | |||
| No resistance (pansusceptible) | 11 | 14 | 16 | 41 | 52.6 |
| Amp | 3 | 1 | 4 | 5.1 | |
| Tio | 1 | 1 | 1.3 | ||
| Tet | 4 | 4 | 5.1 | ||
| Amp, Str | 2 | 2 | 2.6 | ||
| Tet, Amp | 1 | 1 | 1.3 | ||
| Tet, Kan | 1 | 1 | 1.3 | ||
| Gen, Str, Sul | 3 | 3 | 3.9 | ||
| Tet, Kan, Str | 1 | 2 | 2 | 5 | 6.4 |
| Tet, Amp, Kan | 1 | 1 | 1.3 | ||
| Tio, Fox, Amp, Amc | 2 | 2 | 2.6 | ||
| Tet, Kan, Str, Sul | 1 | 1 | 1.3 | ||
| Tet, Amp, Kan, Str | 2 | 2 | 2.6 | ||
| Tet, Amp, Amc, Kan, Str | 1 | 1 | 1.3 | ||
| Tet, Amp, Gen, Kan, Str | 1 | 1 | 1.3 | ||
| Tet, Gen, Kan, Str, Sul | 1 | 1 | 2 | 2.6 | |
| Tet, Tio, Fox, Amp, Amc | 1 | 1 | 1.3 | ||
| Tet, Tio, Fox, Amp, Amc, Kan, Str | 2 | 2 | 2.6 | ||
| Tet, Tio, Fox, Amp, Amc, Kan, Str, Sul | 1 | 1 | 1.3 | ||
| Chl, Tet, Amp, Amc, Gen, Kan, Str, Sul | 1 | 1 | 1.3 | ||
| Chl, Tet, Tio, Fox, Amp, Amc, Gen, Str, Sul, Sxt | 1 | 1 | 1.3 | ||
| Total | 30 | 18 | 30 | 78 | 100 |
Chl, chloramphenicol; Tet, tetracycline; Tio, ceftiofur; Fox, cefoxitin; Amp, ampicillin; Amc, amoxicillin-clavulanic acid; Gen, gentamicin; Kan, kanamycin; Str, streptomycin, Sul, sulfonamides; Sxt, trimethoprim-sulfamethoxazole.
Isolates provided from the Arkansas Public Health Laboratories in 2009 in compliance with the request that multiple isolates from a single outbreak were not included.
Isolates provided from the New York State Department of Health in 2009 in compliance with the request that multiple isolates from a single outbreak were not included.
Isolates provided from the Wisconsin State Laboratory of Hygiene in 2008 in compliance with the request that multiple isolates from a single outbreak were not included. Fifteen isolates from invasive (blood culture) and 15 from gastrointestinal (fecal culture) infections were provided.